{
    "title": "Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.",
    "doc_id": "32849636",
    "writer": "Merle NS",
    "year": "2020",
    "summary": "Intravascular hemolysis of any cause can induce acute kidney injury (AKI). Hemolysis-derived product heme activates the innate immune complement system and contributes to renal damage. Therefore, we explored the role of the master complement regulator Factor H (FH) â€¦",
    "abstract": "Intravascular hemolysis of any cause can induce acute kidney injury (AKI). Hemolysis-derived product heme activates the innate immune complement system and contributes to renal damage. Therefore, we explored the role of the master complement regulator Factor H (FH) in the kidney's resistance to hemolysis-mediated AKI. Acute systemic hemolysis was induced in mice lacking liver expression of FH (hepatoFH-/-, ~20% residual FH) and in WT controls, by phenylhydrazine injection. The impaired complement regulation in hepatoFH-/- mice resulted in a delayed but aggravated phenotype of hemolysis-related kidney injuries. Plasma urea as well as markers for tubular (NGAL, Kim-1) and vascular aggression peaked at day 1 in WT mice and normalized at day 2, while they increased more in hepatoFH-/- compared to the WT and still persisted at day 4. These were accompanied by exacerbated tubular dilatation and the appearance of tubular casts in the kidneys of hemolytic hepatoFH-/- mice. Complement activation in hemolytic mice occurred in the circulation and C3b/iC3b was deposited in glomeruli in both strains. Both genotypes presented with positive staining of FH in the glomeruli, but hepatoFH-/- mice had reduced staining in the tubular compartment. Despite the clear phenotype of tubular injury, no complement activation was detected in the tubulointerstitium of the phenylhydrazin-injected mice irrespective of the genotype. Nevertheless, phenylhydrazin triggered overexpression of C5aR1 in tubules, predominantly in hepatoFH-/- mice. Moreover, C5b-9 was deposited only in the glomeruli of the hemolytic hepatoFH-/- mice. Therefore, we hypothesize that C5a, generated in the glomeruli, could be filtered into the tubulointerstitium to activate C5aR1 expressed by tubular cells injured by hemolysis-derived products and will aggravate the tissue injury. Plasma-derived FH is critical for the tubular protection, since pre-treatment of the hemolytic hepatoFH-/- mice with purified FH attenuated the tubular injury. Worsening of acute tubular necrosis in the hepatoFH-/- mice was trigger-dependent, as it was also observed in LPS-induced septic AKI model but not in chemotherapy-induced AKI upon cisplatin injection. In conclusion, plasma FH plays a key role in protecting the kidneys, especially the tubules, against hemolysis-mediated injury. Thus, FH-based molecules might be explored as promising therapeutic agents in a context of AKI.",
    "link": "https://pubmed.ncbi.nlm.nih.gov/32849636/",
    "clean_text": "circulating fh protects kidneys from tubular injury during systemic hemolysis intravascular hemolysis of any cause can induce acute kidney injury aki hemolysis derived product heme activates the innate immune complement system and contributes to renal damage therefore we explored the role of the master complement regulator factor h fh intravascular hemolysis of any cause can induce acute kidney injury aki hemolysis derived product heme activates the innate immune complement system and contributes to renal damage therefore we explored the role of the master complement regulator factor h fh in the kidney s resistance to hemolysis mediated aki acute systemic hemolysis was induced in mice lacking liver expression of fh hepatofh residual fh and in wt controls by phenylhydrazine injection the impaired complement regulation in hepatofh mice resulted in a delayed but aggravated phenotype of hemolysis related kidney injuries plasma urea as well as markers for tubular ngal kim and vascular aggression peaked at day in wt mice and normalized at day while they increased more in hepatofh compared to the wt and still persisted at day these were accompanied by exacerbated tubular dilatation and the appearance of tubular casts in the kidneys of hemolytic hepatofh mice complement activation in hemolytic mice occurred in the circulation and c b ic b was deposited in glomeruli in both strains both genotypes presented with positive staining of fh in the glomeruli but hepatofh mice had reduced staining in the tubular compartment despite the clear phenotype of tubular injury no complement activation was detected in the tubulointerstitium of the phenylhydrazin injected mice irrespective of the genotype nevertheless phenylhydrazin triggered overexpression of c ar in tubules predominantly in hepatofh mice moreover c b was deposited only in the glomeruli of the hemolytic hepatofh mice therefore we hypothesize that c a generated in the glomeruli could be filtered into the tubulointerstitium to activate c ar expressed by tubular cells injured by hemolysis derived products and will aggravate the tissue injury plasma derived fh is critical for the tubular protection since pre treatment of the hemolytic hepatofh mice with purified fh attenuated the tubular injury worsening of acute tubular necrosis in the hepatofh mice was trigger dependent as it was also observed in lps induced septic aki model but not in chemotherapy induced aki upon cisplatin injection in conclusion plasma fh plays a key role in protecting the kidneys especially the tubules against hemolysis mediated injury thus fh based molecules might be explored as promising therapeutic agents in a context of aki"
}